Skip to content
Moffitt Cancer Center· @MoffittNews · X·· 2026-04-19Score60
Body · original

Happening now at #AACR26: Jean-Christophe Marine, PhD (
@vib_ccb
) presents a framework to monitor and target tumor heterogeneity and plasticity, key drivers of resistance in melanoma.

Key takeaways:
•Personalized and MRD-driven melanoma therapies face multiple, complex

Heat 24 · 14 likes · 1 reply · 9 reposts

Source: Moffitt Cancer Center · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org